Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Duke University
Sponsor:
Information provided by (Responsible Party):
Mitchell Horwitz, MD, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01627275
First received: June 21, 2012
Last updated: October 10, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)